腹主动脉瘤腔内修复术后瘤囊行为的新预测因素
回顾性分析168例成功行EVAR且CTA随访至少1年的腹主动脉瘤患者,瘤囊回缩组79例(47.0%)、未回缩组89例(53.0%)。多因素分析显示,发生植入后综合征(PIS)者瘤囊回缩可能性更高(HR 1.68),而一过性II型内漏(HR 0.43)和随访CTA瘤囊内血栓密度较高(HR 0.97)者回缩可能性更低;瘤囊未回缩与随访期再干预率显著更高相关(p=0.001)。
要点
- 随访CTA瘤囊内血栓密度较高与瘤囊回缩可能性更低相关(HR 0.97,95%CI 0.95-0.99,p=0.013)。
- 一过性II型内漏者瘤囊回缩可能性更低(HR 0.43,95%CI 0.20-0.95,p=0.037)。
- 发生PIS者瘤囊回缩可能性更高(HR 1.68,95%CI 1.07-2.64,p=0.023)。
核心结论
- 除II型内漏外,PIS和随访CTA瘤囊内血栓密度是EVAR术后瘤囊行为的新预测因素,瘤囊回缩与随访期再干预率更低显著相关。
研究设计与样本
- 回顾性分析168例因腹主动脉瘤行成功EVAR且CTA随访至少1年的患者,按瘤囊行为分为回缩组(n=79,47.0%)和未回缩组(n=89,53.0%)。
关键影像表现/征象
- 随访CTA上瘤囊内血栓密度较高者瘤囊回缩可能性更低(HR 0.97,95%CI 0.95-0.99,p=0.013)。
诊断标准与关键数值
- 多因素分析中,PIS与瘤囊回缩可能性更高独立相关(HR 1.68,95%CI 1.07-2.64,p=0.023)。
- 多因素分析中,一过性II型内漏与瘤囊回缩可能性更低独立相关(HR 0.43,95%CI 0.20-0.95,p=0.037)。
- 多因素分析中,随访CTA瘤囊内血栓密度与瘤囊回缩可能性更低独立相关(HR 0.97,95%CI 0.95-0.99,p=0.013)。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: This study aimed to identify new predictors of sac behavior after endovascular aortic aneurysm repair (EVAR) and to investigate whether sac behavior is associated with long-term clinical outcomes.
METHODS: A total of 168 patients undergoing successful EVAR for abdominal aortic aneurysms with CTA follow-up of at least 1 year were included. Predictors of aneurysm sac behavior and its impact on long-term clinical outcomes were retrospectively analyzed.
RESULTS: According to sac behavior, eligible patients were stratified into the sac regression group (n = 79, 47.0%) and the sac non-regression group (n = 89, 53.0%). Patients in the regression group were younger (p = 0.036) and more likely to take sarpogrelate hydrochloride postoperatively (p = 0.011) than those in the non-regression group. The incidence of postimplantation syndrome (PIS) was significantly higher in the regression group (p = 0.005). On multivariate analysis, sac regression was more likely to occur in those with PIS (hazard ratio [HR], 1.68; 95% confidence interval [CI], 1.07-2.64; p = 0.023) and less likely to occur in those with transient type II endoleaks (HR, 0.43; 95% CI, 0.20-0.95; p = 0.037) and higher thrombus density within the sac on follow-up CTA (HR, 0.97; 95% CI, 0.95-0.99; p = 0.013). Non-regression of the sac was associated with significantly higher rates of re-intervention during the follow-up period (p = 0.001).
CONCLUSIONS: In addition to type II endoleaks, PIS and thrombus density are new predictors of aneurysm sac behavior, and sac regression is significantly associated with lower rates of re-intervention.
KEY POINTS: • After endovascular aortic aneurysm repair (EVAR), patients with sac regression were younger and more likely to take sarpogrelate hydrochloride postoperatively than those with sac non-regression. • The incidence of postimplantation syndrome (PIS) was significantly higher in patients with sac regression. • In our analysis, PIS and thrombus density within the sac were newly identified predictors of aneurysm sac behavior after EVAR.
引用
- Jeong MJ, Kwon H, Ko GY, et al. New predictors of aneurysm sac behavior after endovascular aortic aneurysm repair. Eur Radiol. 2019. PMID: 31250171. doi:10.1007/s00330-019-06306-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。